Market Tracker

11/21 6:05pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

5.48
Data as of Nov 21
 +0.65 / +13.46%
Today’s Change
3.78
Today|||52-Week Range
22.50
-50.63%
Year-to-Date

Today’s Trading

Previous close4.83
Today’s open5.00
Day’s range4.80 - 5.65
Volume67,280
Average volume (3 months)23,356
Market cap$70.9M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+87.74%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratioNM
Price/Sales1.73
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc+0.30+5.89%
CYCCCyclacel Pharmaceuti...0.000.00%
MNOVMediciNova Inc-0.04-1.29%
MSTXMast Therapeutics In...-0.01-2.47%
Data as of 4:04pm ET, 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts